生育补充剂市场规模、份额和成长分析（按成分类型、产品、分销管道、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，生育补充剂市场规模将达到 22.6 亿美元，到 2025 年将达到 24.3 亿美元，到 2033 年将达到 44.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.7%。

随着不孕不育率的上升，越来越多的人寻求改善生殖健康的替代方法，生育补充剂市场也因此蓬勃发展。人们对膳食补充剂益处的认识不断提高，以及这些产品供应的日益便利，都大大促进了市场的扩张。然而，市场仍面临许多挑战，例如产品品质参差不齐、高成本以及缺乏科学证据支持其有效性，这些都限制了消费者的获取途径和信任度。此外，社会对不孕症的歧视也可能阻碍人们寻求治疗方案。儘管存在这些障碍，但机会也在不断涌现，例如电子商务的蓬勃发展、产品种类的日益丰富以及个人化营养的趋势。随着越来越多的人寻求非传统方法来提高生育能力，如果这些挑战能够有效解决，市场有望迎来持续成长。

推动生育补充剂市场发展的因素

全球生育力补充剂市场的主要驱动因素之一是夫妻对不孕症问题的日益关注和日益普遍。生活方式的改变、环境因素和饮食习惯等因素都会导致生殖健康状况下降，因此越来越多的个人和夫妻正在寻求有效的解决方案来提高生育能力。这种日益增长的认知得益于教育宣传活动、社群媒体影响者的推广以及营养补充益处资讯的普及。此外，消费者越来越重视天然成分和整体疗法，以维护生殖健康，这进一步推动了生育力补充剂的需求。

抑制生育补充剂市场的因素

全球生育保健品市场的主要限制因素之一是缺乏统一的监管标准和对各类产品的科学检验。儘管许多生育保健品声称能够改善生殖健康，但它们往往缺乏足够的临床证据来支持其有效性，这导致消费者和医疗专业人士对其持怀疑态度。这种不确定性可能会阻碍市场成长，因为人们可能不愿意投资购买未经证实有效的保健品。此外，产品品质和成分的差异会进一步削弱消费者的信任，限制市场扩张，并促使潜在客户转向更成熟的医疗方法。

生育补充剂市场趋势

受消费者对安全性和减少副作用的偏好所驱动，生育补充剂市场正经历着向天然和有机产品显着转变的趋势。随着越来越多的人重视整体健康，对由草药、维生素和矿物质等天然成分组成的生育补充剂的需求持续增长。 Infolic等产品的日益普及便是这一趋势的例证，该产品结合了肌醇和叶酸以支持生殖健康，这标誌着人们在饮食选择方面正朝着更加透明和天然成分的方向发展。因此，市场正在适应这种不断变化的环境，专注于研发符合消费者价值观的配方。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术进步

全球生育补充品市场规模（依成分类型划分）及复合年增长率（2026-2033 年）

• 自然的
• 合成

全球生育补充品市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 胶囊
• 药片
• 软胶囊
• 粉末
• 液体

全球生育补充品市场规模（依通路划分）及复合年增长率（2026-2033 年）

• OTC
• 处方药

全球生育补充品市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 男性
• 女士

全球生育补充品市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Fairhaven Health（USA）
• Coast Science（USA）
• Lenus Pharma GesmbH（Austria）
• Active Bio Life Science GmbH（Germany）
• Orthomol（Germany）
• Exeltis USA, Inc.（USA）
• Bionova（India）
• Fertility Nutraceuticals LLC（USA）
• Vitabiotics Ltd.（UK）
• Extreme V, Inc.（USA）
• Xena Bio Herbals Pvt. Ltd.（India）
• Gonadosan Distribution GmbH（Fertilovit）（Austria）
• InnovaMed Ltd.（Amino Expert）（UK）
• Babystart Ltd.（UK）
• Crown Nutraceuticals（USA）
• Sal Nature LLC（USA）
• Yadtech（Israel）
• Prega News（India）
• PlusPlus Lifesciences LLP（India）

结论与建议

Fertility Supplements Market size was valued at USD 2.26 Billion in 2024 and is poised to grow from USD 2.43 Billion in 2025 to USD 4.41 Billion by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).

The fertility supplements market is gaining traction as individuals seek alternative solutions to enhance reproductive health amid rising infertility rates. Increased awareness surrounding the benefits of dietary supplements and their easy availability contribute significantly to market expansion. However, challenges persist, such as inconsistent product quality, high costs, and a lack of scientific evidence supporting efficacy, which dampen accessibility and confidence among consumers. Additionally, stigma surrounding infertility may deter individuals from pursuing treatment options. Despite these hurdles, opportunities are emerging through the growth of e-commerce, a wider variety of products, and the trend towards personalized nutrition. As more people explore non-traditional routes for improving fertility, the market is poised for growth, provided these challenges are addressed effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fertility Supplements market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fertility Supplements Market Segments Analysis

Global Fertility Supplements Market is segmented by Ingredient Type, Product, Distribution Channel, End User and region. Based on Ingredient Type, the market is segmented into Natural and Synthetic. Based on Product, the market is segmented into Capsules, Tablets, Soft gels, Powders and Liquids. Based on Distribution Channel, the market is segmented into OTC and Prescribed. Based on End User, the market is segmented into Men and Women. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fertility Supplements Market

One of the key market drivers for the global fertility supplements market is the rising awareness and increasing prevalence of infertility issues among couples. As lifestyle changes, environmental factors, and dietary habits contribute to decreased reproductive health, more individuals and couples are seeking effective solutions to enhance fertility. This growing awareness is bolstered by educational initiatives, social media influence, and the availability of information regarding the benefits of nutritional support. Additionally, the trend towards natural and holistic approaches to health and wellness further fuels demand for fertility supplements, as consumers increasingly prioritize natural ingredients and holistic treatment options to support reproductive health.

Restraints in the Fertility Supplements Market

One of the key market restraints for the global fertility supplements market is the lack of regulatory standardization and scientific validation of various products. Many fertility supplements claim to enhance reproductive health but often lack sufficient clinical evidence to support their efficacy, leading to skepticism among consumers and healthcare professionals. This uncertainty can hinder market growth as individuals may be reluctant to invest in supplements without proven benefits. Additionally, the varying quality and ingredients of products can further complicate consumer trust, limiting market expansion and driving potential customers towards more established medical treatments.

Market Trends of the Fertility Supplements Market

The fertility supplements market is experiencing a notable shift towards natural and organic products, driven by consumer preferences for perceived safety and reduced side effects. As individuals prioritize holistic approaches to health, the demand for fertility supplements composed of natural ingredients, including herbs, vitamins, and minerals, continues to rise. This trend is underscored by the increasing popularity of products like Infolic, which combines myo-inositol and folic acid to support reproductive health, showcasing a broader movement towards transparency and natural composition in dietary choices. Consequently, the market is adapting to this evolving landscape by focusing on formulations that align with these consumer values.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Fertility Supplements Market Size by Ingredient Type & CAGR (2026-2033)

• Market Overview
• Natural
• Synthetic

Global Fertility Supplements Market Size by Product & CAGR (2026-2033)

• Market Overview
• Capsules
• Tablets
• Soft gels
• Powders
• Liquids

Global Fertility Supplements Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• OTC
• Prescribed

Global Fertility Supplements Market Size by End User & CAGR (2026-2033)

• Market Overview
• Men
• Women

Global Fertility Supplements Market Size & CAGR (2026-2033)

• North America (Ingredient Type, Product, Distribution Channel, End User)
  • US
  • Canada
• Europe (Ingredient Type, Product, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Ingredient Type, Product, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Ingredient Type, Product, Distribution Channel, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Ingredient Type, Product, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Fairhaven Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coast Science (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lenus Pharma GesmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Active Bio Life Science GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthomol (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exeltis USA, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionova (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fertility Nutraceuticals LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitabiotics Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Extreme V, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xena Bio Herbals Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gonadosan Distribution GmbH (Fertilovit) (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InnovaMed Ltd. (Amino Expert) (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Babystart Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crown Nutraceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sal Nature LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yadtech (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prega News (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PlusPlus Lifesciences LLP (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations